Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vascular targeted photodynamic therapy with WST09 in localized prostate cancer (repeat procedure)
2006-001530-40Phase 2Terminated
- Sponsor
- Steba Biotech
- Start
- May 2006
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of padeliporfin in prostate cancer (PCa), sponsored by Steba Biotech. Primary endpoint: Prostate biopsy result at Month 6. Started May 2006; status: terminated.
02
Drugs
padeliporfin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2006-001530-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001530-40.